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Introduction
The West Nile virus (WNV) is m ost of­
ten spread to hum ans from the bite of an 
infected mosquito. The virus may also be 
transm itted in other ways— through or­
gan transplants, blood transfusions, and 
breast milk, and from m other to fetus.
But the risk of such transm ission is very 
low. WNV was first reported in the United 
States in 1999, and occupational exposures 
have been documented. By 2004, the virus 
was reported throughout the continental 
United States.
M ost hum an infections with W NV (about 80%) cause no symptoms, 
and about 20% cause flu-like symptoms— including fever, fatigue, 
headache, and muscle or jo in t pain. Fewer than 1% of hum ans infected 
w ith W NV become severely ill. Severe symptoms include high fever, 
stiff neck, disorientation, trem ors, muscle weakness, and paralysis. Se­
verely affected persons may develop encephalitis (inflammation of the 
brain) or meningitis (inflammation of the m embranes of the brain or 
spinal cord). Severe cases may be fatal. People of all ages and conditions 
may be affected. However, those who are above age 50 or who have had 
an organ transplant are at increased risk of severe illness.
Frequently Asked Questions
Which workers may be exposed to WNV?
O utdoor, laboratory, field, and clinical workers are at risk o f WNV 
exposure.
W NV is most often spread to humans from  
the bite of an infected mosquito. However, 
the virus may also be transmitted through  
contact with infected animals, their blood, 
or other tissues. Photograph courtesy o f Jim 
Gathany, Centers for Disease Control and 
Prevention (CDC).
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Laboratory workers who handle 
W NV-infected tissues or fluids 
are at risk of W NV exposure.
Field workers are at risk of WNV 
infection from  mosquitoes. They 
also are at risk if they handle 
infected animals or tissues and 
their skin is penetrated or cut. 
Photograph courtesy o f CDC.
Although WNV is m ost often transm itted by the bite of 
infected mosquitoes, the virus can also be transmitted 
through contact with infected animals, their blood, or 
other tissues. Thus laboratory, field, and clinical work­
ers who handle tissues or fluids infected with WNV or 
who perform necropsies are at risk of WNV exposure. 
Outdoor workers are at risk of WNV exposure when­
ever mosquitoes are biting.*
Many types of laboratory workers and workers in 
other occupations may be exposed to WNV. These 
workers include laboratory diagnosticians and tech­
nicians, pathologists, researchers, veterinarians and 
their staff, wildlife rehabilitators, entomologists, orn i­
thologists, wildlife biologists, zoo and aviary curators, 
health care workers, emergency response and public 
safety personnel, public health workers, and others in 
related occupations.
Who is at risk of WNV infection?
Workers who handle and process WNV-infected tis­
sues or animals are at risk of infection if their skin is 
penetrated or cut. Also, anyone who lives or works in 
an area where there are WNV-infected mosquitoes is 
at risk of WNV infection. People of all ages are at risk 
of the flu-like symptoms of this infection. Although 
people usually recover, the symptoms may be severe 
enough to result in lost workdays for extended periods.
*See Recommendations for Protecting Outdoor Workers from  West 
Nile Virus Exposure (NIOSH Publication No. 2005-155). Single 
copies are available free from  NIOSH (1-800-35-N IO SH ); or 
visit the NIOSH Web site at www.cdc.gov/niosh.
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People above age 50 and those who have had organ 
transplants are known to have the highest risk of 
severe illness from W NV infection. Others w ith com ­
promised im m une systems are also likely to be at high 
risk. However, people of all ages and conditions can 
become severely ill. Therefore, ALL workers should be 
careful to follow the recom mendations listed in this 
brochure to reduce their potential for WNV exposure 
and infection. W hen workers are outside, they should 
also follow the recommendations for outdoor workers.
Have any laboratory workers been infected 
with WNV on the job?
Laboratory workers have been infected w ith WNV on 
the job. One case involved a worker whose skin was 
cut w ith a scalpel while doing a necropsy of an in ­
fected bird. Another worker was infected as a result of 
a finger puncture w ith a contam inated needle.
What should I do if I must handle dead 
animals?
Avoid handling dead animals when possible. If you 
m ust handle them, avoid direct contact and wear 
gloves that provide a protective barrier. See additional 
recom m endations at the end of this brochure.
How does WNV affect a woman's pregnancy?
The Centers for Disease Control and Prevention 
(CDC) has followed a num ber of women who became 
ill with WNV during pregnancy. Most of these women 
delivered apparently healthy babies with no evidence
Wear gloves if you must handle 
dead animals.
Laboratory workers have 
infected with W NV on the job
Photograph courtesy o f CDC.
.it
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When pregnant workers are outside, 
they should avoid mosquitoes, 
wear protective clothing, and use 
an effective repellent. Photograph 
courtesy o f CDC.
of WNV infection. Although some of the babies born 
to WNV-infected mothers did have health problems, it 
is unknown whether the WNV infection caused these 
problems. Because of the lim ited num ber of cases 
studied so far, it is no t yet possible to determ ine what 
percentage of WNV infections during pregnancy result 
in infection of the fetus or medical problems in new­
borns. More research is needed to understand the pos­
sible effects of WNV on pregnancy.
Pregnant workers should follow the recommenda­
tions at the end of this brochure to reduce their risk for 
WNV infection. W hen pregnant workers are outside, 
they should also follow recommendations for outdoor 
workers,f which include avoiding mosquitoes; wearing 
protective clothing; using repellents containing DEET 
(N,N-diethyl-m-toluamide), picaridin, or oil of lemon 
eucalyptus on the skin; and spraying clothes with one 
of these repellents or permethrin. Always follow label 
instructions for repellents. Pregnant women who be­
come ill should see their health care providers.
What should I do if I suspect I have been 
infected with WNV?
■ Im m ediately repo rt any laborato ry  incidents 
involving possible W NV exposure to your 
supervisor.
tSee Recommendations for Protecting Outdoor Workers from  West 
Nile Virus Exposure (NIOSH Publication No. 2005-155). Single 
copies are available free from  NIOSH (1-800-35-N IO SH ); or 
visit the NIOSH Web site at www.cdc.gov/niosh.
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■ Contact your health care provider if you have 
health concerns.
The period between exposure to WNV and having 
symptoms is 3 to 14 days. Testing for WNV infection 
is available. No vaccine is currently available to pre­
vent WNV infection in humans.
Recommendations for Employers 
of Laboratory, Field, and Clinical 
Workers
Employers of laboratory, field, and clinical workers 
should protect their workers from WNV exposure by 
taking the following steps:
■ Provide training that describes how WNV is 
transm itted and reinforces knowledge about 
the risks of W NV exposure and infection.
■ Supply workers w ith appropriate personal p ro­
tective equipm ent that provides barrier protec­
tion— such as gloves, gowns, masks, goggles
or glasses w ith solid side shields, and/or chin- 
length face shields.
■ Provide alternatives to latex gloves for workers 
who need or w ant to avoid latex.
■ Stress to workers the im portance of report­
ing all work-related injuries and illnesses in a 
timely manner.
Visit your health care provider if 
you develop W NV symptoms.
Supply workers with gloves 
that provide barrier protection.
Photograph courtesy o f Kimberly 
Smith and Christine Ford, CDC.
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Wear medical examination
gloves that provide a protective 
barrier between blood or other 
body fluids and your skin. Wear 
cotton or leather work gloves as 
the outer pair when heavy work  
gloves are needed.
■ Provide a medical surveillance system that 
monitors, records, and assesses the following:
—  Symptoms consistent with WNV infection
—  Laboratory incidents involving possible 
WNV exposure
—  Absenteeism associated with WNV infec­
tion
Recommendations for Laboratory, 
Field, and Clinical Workers
Avoid handling dead animals when possible. If you 
m ust handle them, take the following precautions:
■ Use tools such as shovels to avoid direct con­
tact w ith the animals.
■ Wear medical examination gloves that provide 
a protective barrier between blood or other 
body fluids and your skin:
—  Wear two pairs of gloves if one pair alone 
m ight tear.
—  Make sure that latex gloves are reduced- 
protein, powder-free gloves to reduce 
w orkers’ exposure to allergy-causing 
proteins.
—  Wear cotton or leather work gloves as the 
outer pair when heavy work gloves are 
needed.
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—  Wear the medical examination gloves as 
the inner pair.
—  Discard both inner and outer gloves im ­
mediately after use.
—  Remember that cotton, leather, and other 
absorbent gloves are no t protective when 
worn alone.
■ Avoid skin and mucous m em brane contact 
w ith blood and other tissues by using personal 
protective equipm ent that provides barrier 
protection— such as gloves, gowns, masks, gog­
gles or glasses w ith solid side shields, and/or 
chin-length face shields.
■ Wash hands and other skin surfaces with soap 
and water immediately after contact with 
blood or other tissues, after removing gloves, 
and before leaving the workplace.
■ Take precautions when using scalpels, forceps, 
and other sharp instruments.
■ Use medical devices with safety features to 
avoid sharps-related injuries.
■ Do no t recap, bend, or remove contaminated 
needles and sharps. Never shear or break con­
tam inated needles.
■ Dispose of sharp devices in labeled, puncture- 
resistant, leakproof sharps disposal containers 
immediately after use.
Promptly dispose of contaminated 
materials in containers approved 
for biohazardous wastes.
Photograph courtesy o f Kimberly Smith 
and Christine Ford, CDC.
Dispose of sharp devices in 
sharps disposal containers 
im m ediately after use. Photograph 
courtesy o f Jim Gathany, CDC.
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■ Immediately after use, dispose of materials 
contam inated by infected animals, their blood, 
or other tissues in containers approved for bio­
hazardous wastes.
■ Minimize the generation of aerosols when 
working w ith infected tissues, samples, and 
animals.
■ Immediately report the following to the super­
visor:
—  All needlestick and other sharps-related 
injuries
—  Any laboratory incidents involving pos­
sible W NV exposure
—  Any symptoms consistent with WNV in­
fection
Resources
For m ore comprehensive inform ation about WNV, 
contact the Division of Vector-Borne Infectious Dis­
eases, National Center for Infectious Diseases, Centers 
for Disease Control and Prevention at
www.cdc.gov/westnile
For further inform ation about occupational safety 
and health topics, contact the National Institute for 
Occupational Safety and Health, Centers for Disease 
Control and Prevention at
www.cdc.gov/niosh
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For further inform ation about the OSHA Bloodborne 
Pathogens Standard, contact the Occupational Safety 
and Health Administration at
www.osha.gov/SLTC/bloodbornepathogens
For the complete text of the U.S. D epartm ent of 
Health and H um an Services publication Biosafety in 
Microbiological and Biomedical Laboratories (4th edi­
tion, 1999), see
http://bm bl.od.nih.gov/
For further inform ation about biosafety, contact the 
Office of Health and Safety, Centers for Disease Con­
trol and Prevention at
www.cdc.gov/od/ohs/biosfty/biosfty.htm
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